Device Trial Radar · NCT01752192
Teledi@Log - Tele-rehabilitation of Heart Patients
Last checked: Nov 20, 2026Latest source record: Dec 30, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Aalborg UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- KMD; International Business Machines (IBM); Tunstall Healthcare; Oscar Film; Roche Pharma AG; SOS International; Danish Heart Foundation; Hjoerring Municipaility; Frederikshavn Municipality; Regionshospital Nordjylland; Aalborg University Hospital; University of Aarhus; GP in the Municipalities of Hjoerring and Frederikshavn; EIR (Empowering Industry and Research)
- First posted
- Dec 19, 2012
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (care provider, investigator)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The idea behind the Teledi@log consortium is to develop tele-rehabilitation concepts and technologies so that all types of heart disease patients, regardless of degree of severity, can be offered individual, customized and coordinated tele-rehabilitation across sectors. The project is innovative, breaking new ground in relation to existing national and international research projects in the area. The Teledi@log consortium sees its major task as developing and testing scenarios which can lead to a more coherent rehabilitation for heart patients in areas such as patient training, organization across the boundaries of the health system and using tele-rehabilitation technology. The Teledi@log consortium seeks to develop new tele-rehabilitation concepts which bring the patient closer to the health system and thereby promote the heart patient's rehabilitation, giving the patient and their families a more active role via new tele-rehabilitation technologies.The hypothesis of the study is that heart patients participating in a telerehabilitation program will have a higher quality of life compared to heart patients following traditional rehabilitation activities.
Conditions
- Heart Failure
- Myocardial Infarction
- Angina Pectoris
- Coronary Stenosis
- Mitral Valve Stenosis
Interventions
Telerehabilitation programmeDevice
Telerehabilitation programme: Each patient in the intervention group will use a telehealth monitor. The patient will measure blood pressure, pulse and weight once or twice a week over a 3 months periode with the use of a blood pressure monitor and a weightscale connected to the monitor. The patients will also measure their steps daily by the use of a digital stepcounter. The patients will be able to see their data in a personal health record on a tablet where they can share informations with their GP, nurse and doctor at the hospital or healthcare center. The patient are also offered access to a portal called www.aktivehjerte.dk where they can find informations on rehabilitations topics in text, video and sound.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Quality of lifeTime frame: At inclusion (baseline), change from baseline at 3, 6 and 12 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Thoracic Ward, Aalborg University Hospital
Aalborg, Denmark
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.